Chapter PDF
References
Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554
Alberti C, Brun-Buisson C, Burchardi H, et al (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310
De Maio A, Torres MB, Reeves RH (2005) Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 23:11–17
Arcaroli J, Fessler MB, Abraham E (2005) Genetic polymorphisms and sepsis. Shock 24:300–312
Dahmer MK, Randolph A, Vitali S, Quasney MW (2005) Genetic polymorphisms in sepsis. Pediatr Crit Care Med 6:S61–73
Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JP (2005) The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 41(Suppl 7):S408–415
Texereau J, Pene F, Chiche JD, Rousseau C, Mira JP (2004) Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis. Crit Care Med 32:S313–319
Worthley DL, Bardy PG, Mullighan CG (2005) Mannose-binding lectin: biology and clinical implications. Intern Med J 35:548–555
Frodsham AJ, Hill AV (2004) Genetics of infectious diseases. Hum Mol Genet 13 Spec No 2:R187–194
Hernandez-Valladares M, Naessens J, Iraqi FA (2005) Genetic resistance tomalaria in mouse models. Trends Parasitol 21:352–355
Stewart D, Fulton WB, Wilson C, et al (2002) Genetic contribution to the septic response in a mouse model. Shock 18:342–347
Knuefermann P, Sakata Y, Baker JS, et al (2004) Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 110:3693–3698
Takeuchi O, Hoshino K, Kawai T, et al (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443–451
Drennan MB, Nicolle D, Quesniaux VJ, et al (2004) Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 164:49–57
Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K (2004) Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 11:625–626
Bochud PY, Hawn TR, Aderem A (2003) Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 170:3451–3454
Kang TJ, Chae GT(2001) Detection of Toll-like receptor 2 (TLR2)mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31:53–58
Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA (2000) A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68:6398–6401
Ogus AC, Yoldas B, Ozdemir T, et al (2004) The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23:219–223
Lin WJ, Wang CC, Lo WT, Chu ML, Lee CM (2005) Dizygotic twins discordant for early-onset Citrobacter koseri and group B streptococcal sepsis. J Formos Med Assoc 104:367–369
Malaty HM, Engstrand L, Pedersen NL, Graham DY (1994) Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 120:982–986
Simonds B (1957) The collection of 300 twin index cases for a study of tuberculosis in twins and their families. Acta Genet Stat Med 7:42–47
Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW (1988) Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318:727–732
Wang JE (2005) Can single nucleotide polymorphisms in innate immune receptors predict development of septic complications in intensive care unit patients? Crit Care Med 33:695–696
Yuan FF, Tanner J, Chan PK, et al (2005) Influence of Fcgamma RIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens 66:291–296
Puel A, Yang K, Ku CL, et al (2005) Heritable defects of the human TLR signalling pathways. J Endotoxin Res 11:220–224
Picard C, Casanova JL (2005) Novel primary immunodeficiencies. Adv Exp Med Biol 568:89–99
de Vries E (2001) Immunological investigations in children with recurrent respiratory infections. Paediatr Respir Rev 2:32–36
Cunningham-Rundles C, Ponda PP (2005) Molecular defects in T-and B-cell primary immunodeficiency diseases. Nat Rev Immunol 5:880–892
Casanova JL, Fieschi C, Bustamante J, et al (2005) From idiopathic infectious diseases to novel primary immunodeficiencies. J Allergy Clin Immunol 116:426–430
Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20:581–620
Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352:1992–2001
Drumm ML, Konstan MW, Schluchter MD, et al (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353:1443–1453
Hirschhorn JN (2005) Genetic approaches to studying common diseases and complex traits. Pediatr Res 57:74R–77R
Burton PR, Tobin MD, Hopper JL (2005) Key concepts in genetic epidemiology. Lancet 366:941–951
Cooper DN, Nussbaum RL, Krawczak M (2002) Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 110:207–208
Hattersley AT, McCarthy MI (2005) What makes a good genetic association study? Lancet 366:1315–1323
Vitali SH, Randolph AG (2005) Assessing the quality of case-control association studies on the genetic basis of sepsis. Pediatr Crit Care Med 6:S74–77
Ulevitch RJ, Mathison JC, da Silva Correia J (2004) Innateimmune responses during infection. Vaccine 22(Suppl 1):S25–30
Vivier E, Malissen B (2005) Innate and adaptive immunity: specificities and signaling hierarchies revisited. Nat Immunol 6:17–21
Lin MT, Albertson TE (2004) Genomic polymorphisms in sepsis. Crit Care Med 32:569–579
Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO (2006) Mannose-binding lectin and its genetic variants. Genes Immun 7:85–94
Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M (1999) Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 353:1049–1053
Roy S, Knox K, Segal S, et al (2002) MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359:1569–1573
Garred P, JJ S, Quist L, Taaning E, Madsen HO (2003) Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 188:1394–1403
van der Pol WL, Huizinga TW, Vidarsson G, et al (2001) Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. J Infect Dis 184:1548–1555
Schroder NW, Schumann RR (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5:156–164
Arbour NC, Lorenz E, Schutte BC, et al. (2000) TLR4mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–191
Lorenz E, Mira JP, Frees KL, Schwartz DA (2002) Relevance ofmutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028–1032
Child NJ, Yang IA, Pulletz MC, et al (2003) Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem Soc Trans 31:652–653
Emonts M, Hazelzet JA, de Groot R, Hermans PW (2003) Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3:565–577
Sutherland AM, Walley KR, Russell JA (2005) Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 33:638–644
Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L (2002) Association between a genomic polymorphismwithin the CD14 locus and septic shock susceptibility andmortality rate. Crit Care Med 30:969–973
D’Avila LC, Albarus MH, Franco CR, et al (2006) Effect of CD14-260C>T polymorphismon the mortality of critically ill patients. Immunol Cell Biol 84:342–348
Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M (2002) The-260C->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in traumapatients. Intensive Care Med 28:1161–1163
Adrie C, Alberti C, Chaix-Couturier C, et al (2005) Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 20:46–58
Ulloa L, Tracey KJ (2005) The “cytokine profile”: a code for sepsis. Trends Mol Med 11:56–63
Haukim N, Bidwell JL, Smith AJ, et al (2002) Cytokine gene polymorphismin human disease: on-line databases, supplement 2. Genes Immun 3:313–330
Dinarello CA (2003) Anti-cytokine therapeutics and infections. Vaccine 21(Suppl 2):S24–34
Pociot F, Molvig J, Wogensen L, et al (1991)Atumour necrosis factor beta gene polymorphism in relation tomonokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 33:37–49
Heesen M, Kunz D, Bachmann-Mennenga B, Merk HF, Bloemeke B (2003) Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 31:211–214
Gimenez F, Barraud de Lagerie S, Fernandez C, Pino P, Mazier D (2003) Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 60:1623–1635
Imahara SD, O’Keefe GE (2004) Genetic determinants of the inflammatory response. Curr Opin Crit Care 10:318–324
Mira JP, Cariou A, Grall F, et al (1999) Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561–568
Hedberg CL, Adcock K, Martin J, Loggins J, Kruger TE, Baier RJ (2004) Tumor necrosis factor alpha — 308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr Infect Dis J 23:424–428
Gordon AC, Lagan AL, Aganna E, et al (2004) TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun 5:631–640
Peters DL, Barber RC, Flood EM, Garner HR, O’Keefe GE (2003) Methodologic quality and genotyping reproducibility in studies of tumor necrosis factor-308 G->A single nucleotide polymorphismand bacterial sepsis: implications for studies of complex traits. Crit Care Med 31:1691–1696
Scumpia PO, Moldawer LL (2005) Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med 33:S468–S471
Neidhardt R, Keel M, Steckholzer U, et al (1997) Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 42:863–870
Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL (1997) Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12:183–187
Kremer Hovinga JA, Franco RF, Zago MA, Ten Cate H, Westendorp RG, Reitsma PH (2004) A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease. J Thromb Haemost 2:54–57
de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI (2005) Heritability estimates of innate immunity: an extended twin study. Genes Immun 6:167–170
Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915–3922
Mozzato-Chamay N, Mahdi OS, Jallow O, Mabey DC, Bailey RL, Conway DJ (2000) Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis-endemic population. J Infect Dis 182:1545–1548
Helminen ME, Kilpinen S, Virta M, Hurme M (2001) Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 184:777–780
Gallagher PM, Lowe G, Fitzgerald T, et al (2003) Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58:154–156
Lowe PR, Galley HF, Abdel-Fattah A, Webster NR (2003) Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 31:34–38
Wattanathum A, Manocha S, Groshaus H, Russell JA, Walley KR (2005) Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest 128:1690–1698
Menges T, Hermans PW, Little SG, et al (2001) Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet 357:1096–1097
Geishofer G, Binder A, Muller M, et al (2005) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr 164:486–490
Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M (2003) Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med 31:2788–2793
Cariou A, Chiche JD, Charpentier J, Dhainaut JF, Mira JP (2002) The era of genomics: impact on sepsis clinical trial design. Crit Care Med 30:S341–348
Bashyam MD, Hasnain SE (2003) The human genome sequence: impact on health care. Indian J Med Res 117:43–65
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Texereau, J., Lemiale, V., Mira, J.P. (2007). Genetics and Severe Sepsis. In: Abraham, E., Singer, M. (eds) Mechanisms of Sepsis-Induced Organ Dysfunction and Recovery. Update in Intensive Care and Emergency Medicine, vol 44. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30328-6_2
Download citation
DOI: https://doi.org/10.1007/3-540-30328-6_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30157-8
Online ISBN: 978-3-540-30328-2
eBook Packages: MedicineMedicine (R0)